Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: J Infect. 2018 Jun 30;77(5):427–434. doi: 10.1016/j.jinf.2018.06.008

Table 1.

Serogroup distribution of U.S. ABCs isolates characterized in this study.

Serogroup 2000–2005 No. of isolates (%) 2006–2010 No. of isolates (%) 2011–2015 No. of isolates (%) P value 2006–10 vs. 2011–15
A 1 (0.10) 0 (0) 0 (0) N/A
C 277 (29.03) 173 (31.11) 88 (28.54) 0.43
Y 319 (33.43) 207 (37.22) 84 (27.25) <0.0001
W 27 (2.83) 22 (3.96) 40 (12.97) 0.0029
B* 298 (31.26) 129 (23.22) 79 (25.72) 0.41
NG 29 (3.04) 19 (3.42) 17 (5.51) 0.14
Other 3 (0.31) 6 (1.08) 0 (0) N/A
Total Isolates 954 556 308

Results for 2000–05 [17] and 2006–10 [18] were reported previously. Nongroupable isolates are abbreviated NG.

*

Serogroup B isolates are represented as weighted values. Serogroup B isolates from Oregon are assigned a value of 0.10, while isolates from all other states are assigned 0.90. The uncorrected total number of isolates collected in each time period are 1175 in 2000–05, 638 in 2006–10, and 349 in 2011–15.